Lusvertikimab (Anti-IL-7Ra / CD127)
Lusvertikimab (Anti-IL-7Ra / CD127) is a humanized monoclonal antibody targeting IL7R. It has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research. MW :145.64 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2669 |
| Sku # | A2669-1mg*5 |
| Pricing | 1mg*5, $970.00 |